Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Genomic Health, Inc.    GHDX   US37244C1018

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/25/2014 07/28/2014 07/29/2014 07/30/2014 07/31/2014 Date
26.73(c) 25.98(c) 26.21(c) 26.35(c) 25.48(c) Last
92 523 111 930 154 767 129 628 96 376 Volume
+0.30% -2.81% +0.89% +0.53% -3.30% Change
More quotes
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
Surperformance© rating of Genomic Health, Inc.
Trading Rating : Investor Rating :
More about the company
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 282 M
EBIT 2014 -28,6 M
Net income 2014 -28,6 M
Finance 2014 57,4 M
Yield 2014 -
Sales 2015 316 M
EBIT 2015 -18,0 M
Net income 2015 -19,5 M
Finance 2015 65,6 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 2,62x
EV / Sales 2015 2,31x
Capitalization 796 M
More Financials
Latest news on GENOMIC HEALTH, INC.
1d ago GENOMIC HEALTH : to Announce Second Quarter 2014 Financial Results and Host Conf..
06/19 GENOMIC HEALTH : Change in Directors or Principal Officers (form 8-K)
06/19 GENOMIC HEALTH : Announces Positive Topline Results of Second Large, Independent..
06/11 GENOMIC HEALTH : Multiple Studies Presented at ASCO® Annual Meeting Demonstrate ..
06/11 GENOMIC HEALTH : Announces Positive Topline Results of Second Large, Independent..
06/10 GENOMIC HEALTH : Submission of Matters to a Vote of Security Holders (form 8-K)
06/10 GENOMIC HEALTH : Assigned Patent
06/10 GENOMIC HEALTH : Multiple studies presented at 2014 ASCO® annual meeting reinfor..
06/04 GENOMIC HEALTH : Oncotype DX® Breast Cancer Test Predicts Late Recurrence Five t..
06/03 GENOMIC HEALTH : Demonstrates the Importance of Utilizing Multiple Biological Pa..
06/01 GENOMIC HEALTH : Multiple Studies Presented at ASCO® Annual Meeting Demonstrate ..
05/29 GENOMIC HEALTH : Oncotype DX® Breast Cancer Test Predicts Late Recurrence Five t..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
Genomic Health, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Genomic Health, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF